These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7825246)

  • 21. The quality of life and self-efficacy of Turkish breast cancer patients undergoing chemotherapy.
    Akin S; Can G; Durna Z; Aydiner A
    Eur J Oncol Nurs; 2008 Dec; 12(5):449-56. PubMed ID: 18842460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in long-term breast cancer survivors: nationwide survey in Denmark.
    Peuckmann V; Ekholm O; Rasmussen NK; Møller S; Groenvold M; Christiansen P; Eriksen J; Sjøgren P
    Breast Cancer Res Treat; 2007 Jul; 104(1):39-46. PubMed ID: 17009107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer.
    Mills PJ; Parker B; Dimsdale JE; Sadler GR; Ancoli-Israel S
    Biol Psychol; 2005 Apr; 69(1):85-96. PubMed ID: 15740827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients.
    Kayl AE; Meyers CA
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):24-8. PubMed ID: 16493256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combo drug therapy doubles breast cancer survival rates. Early treatment with Tamoxifen-chemotherapy combination often extends life.
    Health News; 2005 Aug; 11(8):3-4. PubMed ID: 16184637
    [No Abstract]   [Full Text] [Related]  

  • 26. The significance of the site of recurrence to subsequent breast cancer survival.
    Imkampe A; Bendall S; Bates T
    Eur J Surg Oncol; 2007 May; 33(4):420-3. PubMed ID: 17049430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aromatase inhibitors in breast cancer therapy].
    Joensuu H
    Duodecim; 2004; 120(11):1301-4. PubMed ID: 15327081
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prognosis and adjuvant chemotherapy of axillary node-negative breast cancer patients].
    Han Q; Shen Z; Yu L
    Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):580-2. PubMed ID: 10678041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychosocial factors and breast cancer].
    Groth A
    Ugeskr Laeger; 1993 Mar; 155(11):818-9. PubMed ID: 8460440
    [No Abstract]   [Full Text] [Related]  

  • 30. Depression, quality of life and breast cancer: a review of the literature.
    Reich M; Lesur A; Perdrizet-Chevallier C
    Breast Cancer Res Treat; 2008 Jul; 110(1):9-17. PubMed ID: 17674188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of quality of treatment on prognosis in primary breast cancer patients treated in daily practice.
    Ottevanger PB; De Mulder PH; Grol RP; Van Lier H; Beex LV
    Anticancer Res; 2002; 22(1A):459-65. PubMed ID: 12017333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
    Winer EP; Berry DA; Woolf S; Duggan D; Kornblith A; Harris LN; Michaelson RA; Kirshner JA; Fleming GF; Perry MC; Graham ML; Sharp SA; Keresztes R; Henderson IC; Hudis C; Muss H; Norton L
    J Clin Oncol; 2004 Jun; 22(11):2061-8. PubMed ID: 15169793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables.
    Goodwin PJ; Ennis M; Bordeleau LJ; Pritchard KI; Trudeau ME; Koo J; Hood N
    J Clin Oncol; 2004 Oct; 22(20):4184-92. PubMed ID: 15483029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary chemotherapy in breast cancer.
    Smith IE; al-Moundhri M
    Biomed Pharmacother; 1998; 52(3):116-21. PubMed ID: 9755804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
    Efficace F; Therasse P; Piccart MJ; Coens C; van Steen K; Welnicka-Jaskiewicz M; Cufer T; Dyczka J; Lichinitser M; Shepherd L; de Haes H; Sprangers MA; Bottomley A
    J Clin Oncol; 2004 Aug; 22(16):3381-8. PubMed ID: 15310784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer.
    Pitot HC; Loprinzi CL
    Cancer Chemother Biol Response Modif; 1992; 13():565-87. PubMed ID: 1389920
    [No Abstract]   [Full Text] [Related]  

  • 37. Mind matters -- group therapy and survival in breast cancer.
    Spiegel D
    N Engl J Med; 2001 Dec; 345(24):1767-8. PubMed ID: 11742052
    [No Abstract]   [Full Text] [Related]  

  • 38. [Improved prognosis in breast cancer].
    Sørensen B
    Ugeskr Laeger; 1995 Aug; 157(32):4471. PubMed ID: 7483032
    [No Abstract]   [Full Text] [Related]  

  • 39. Metastatic breast cancer. Length and quality of life.
    Norton L
    N Engl J Med; 1991 Nov; 325(19):1370-1. PubMed ID: 1922240
    [No Abstract]   [Full Text] [Related]  

  • 40. [Improved prognosis in breast cancer].
    Dombernowsky P
    Ugeskr Laeger; 1995 May; 157(20):2865-6. PubMed ID: 7785105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.